• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics: 2nd Edition".专刊编辑按语:“癌症生物学与治疗学的当前研究:第二版”
Int J Mol Sci. 2024 Nov 2;25(21):11777. doi: 10.3390/ijms252111777.
2
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies.神经肽 Y 肽家族与癌症:抗肿瘤治疗策略。
Int J Mol Sci. 2023 Jun 9;24(12):9962. doi: 10.3390/ijms24129962.
3
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.肌浆/内质网钙 ATP 酶抑制剂:超越抗癌视角。
J Med Chem. 2020 Mar 12;63(5):1937-1963. doi: 10.1021/acs.jmedchem.9b01509. Epub 2020 Feb 17.
4
NK-1 receptor antagonists: a new generation of anticancer drugs.NK-1 受体拮抗剂:新一代抗癌药物。
Mini Rev Med Chem. 2012 Jun;12(7):593-9. doi: 10.2174/138955712800626692.
5
Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma.靶向索拉非尼耐药人甲状腺乳头状癌细胞的抗癌 SERCA 抑制剂。
Int J Mol Sci. 2023 Apr 11;24(8):7069. doi: 10.3390/ijms24087069.
6
Editorial [ Special board members issue (Edior-in-chief: Michelle Prudhomme)].社论[特别委员会成员专刊(主编:米歇尔·普鲁多姆)]
Anticancer Agents Med Chem. 2012 Mar;12(3):176. doi: 10.2174/187152012800228832.
7
New Small-Molecule SERCA Inhibitors Enhance Treatment Efficacy in Lenvatinib-Resistant Papillary Thyroid Cancer.新型小分子 SERCA 抑制剂增强仑伐替尼耐药甲状腺乳头状癌的治疗效果。
Int J Mol Sci. 2024 Oct 3;25(19):10646. doi: 10.3390/ijms251910646.
8
Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer.发现针对患者衍生索拉非尼耐药甲状腺乳头状癌的新型抗癌药物。
Int J Mol Sci. 2023 Nov 16;24(22):16413. doi: 10.3390/ijms242216413.
9
Targeting oncogenic Notch signaling with SERCA inhibitors.针对致癌性 Notch 信号通路的 SERCA 抑制剂。
J Hematol Oncol. 2021 Jan 6;14(1):8. doi: 10.1186/s13045-020-01015-9.
10
Curcumin induces endoplasmic reticulum stress-associated apoptosis in human papillary thyroid carcinoma BCPAP cells via disruption of intracellular calcium homeostasis.姜黄素通过破坏细胞内钙稳态诱导人甲状腺乳头状癌BCPAP细胞内质网应激相关凋亡。
Medicine (Baltimore). 2018 Jun;97(24):e11095. doi: 10.1097/MD.0000000000011095.

本文引用的文献

1
Descriptive Analysis of Common Fusion Mutations in Papillary Thyroid Carcinoma in Hungary.匈牙利甲状腺乳头状癌常见融合突变的描述性分析。
Int J Mol Sci. 2024 Oct 8;25(19):10787. doi: 10.3390/ijms251910787.
2
Glioma and Peptidergic Systems: Oncogenic and Anticancer Peptides.神经胶质瘤与肽系统:致癌肽与抑癌肽。
Int J Mol Sci. 2024 Jul 22;25(14):7990. doi: 10.3390/ijms25147990.
3
PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer through a Multimodal Patient Journey: Case Reports and Literature Review.多模式患者病程中上皮性卵巢癌脑转移应用 PARP 抑制剂:病例报告及文献复习。
Int J Mol Sci. 2024 Jul 18;25(14):7887. doi: 10.3390/ijms25147887.
4
Suppressing Anaphase-Promoting Complex/Cyclosome-Cell Division Cycle 20 Activity to Enhance the Effectiveness of Anti-Cancer Drugs That Induce Multipolar Mitotic Spindles.抑制后期促进复合物/周期蛋白依赖性激酶 20 活性以增强诱导多极有丝分裂纺锤体的抗癌药物的疗效。
Int J Mol Sci. 2024 Jun 7;25(12):6329. doi: 10.3390/ijms25126329.
5
Targeting Colorectal Cancer: Unravelling the Transcriptomic Impact of Cisplatin and High-THC Cannabis Extract.靶向结直肠癌:揭示顺铂和高四氢大麻酚大麻提取物的转录组学影响
Int J Mol Sci. 2024 Apr 18;25(8):4439. doi: 10.3390/ijms25084439.
6
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics".《“癌症生物学与治疗学当前研究”特刊》社论
Int J Mol Sci. 2024 Feb 28;25(5):2802. doi: 10.3390/ijms25052802.
7
Biomarker Identification through Proteomics in Colorectal Cancer.通过蛋白质组学在结直肠癌中进行生物标志物鉴定。
Int J Mol Sci. 2024 Feb 14;25(4):2283. doi: 10.3390/ijms25042283.
8
The Effect of 4-(Dimethylamino)phenyl-5-oxopyrrolidines on Breast and Pancreatic Cancer Cell Colony Formation, Migration, and Growth of Tumor Spheroids.4-(二甲氨基)苯基-5-氧代吡咯烷对乳腺癌和胰腺癌肿瘤球状体细胞集落形成、迁移和生长的影响。
Int J Mol Sci. 2024 Feb 2;25(3):1834. doi: 10.3390/ijms25031834.
9
Anti-Algics in the Therapeutic Response of Breast and Urological Cancers.抗阿尔吉斯治疗在乳腺癌和泌尿系统癌症中的作用。
Int J Mol Sci. 2023 Dec 29;25(1):468. doi: 10.3390/ijms25010468.

专刊编辑按语:“癌症生物学与治疗学的当前研究:第二版”

Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics: 2nd Edition".

机构信息

Laboratory of Neuroanatomy of the Peptidergic Systems, Institute of Neurosciences of Castilla and León (INCYL), University of Salamanca, c/Pintor Fernando Gallego 1, 37007 Salamanca, Spain.

出版信息

Int J Mol Sci. 2024 Nov 2;25(21):11777. doi: 10.3390/ijms252111777.

DOI:10.3390/ijms252111777
PMID:39519328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11545955/
Abstract

In the second edition of this Special Issue, several promising antitumor strategies have been presented in addition to those reported in the first edition, in which several compounds (acetylcorynoline, BaP1, sarco/endoplasmic reticulum calcium ATPase inhibitors, neuropeptide Y, neuropeptide Y antagonists, neurokinin-1 receptor antagonists) exerting antitumor effects against colorectal cancer, papillary thyroid carcinoma, cholangiocarcinoma, Ewing sarcoma, liver cancer, and breast cancer were reported [...].

摘要

在本特刊的第二版中,除了第一版中报道的几种化合物(乙酰考尼辛、BaP1、肌浆/内质网钙 ATP 酶抑制剂、神经肽 Y、神经肽 Y 拮抗剂、神经激肽-1 受体拮抗剂)对结直肠癌、甲状腺乳头状癌、胆管癌、尤文肉瘤、肝癌和乳腺癌具有抗肿瘤作用外,还介绍了其他一些有前途的抗肿瘤策略。